Insulin resistance and coronary artery disease

Diabetologia

Volumn 39, Issue 11, 1996, Pages 1345-1350

  Bressler, P ^a   Bailey, S R ^a   Matsuda, M ^a   DeFronzo, R A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Coronary artery disease; Glucose metabolism; Hyperinsulinaemia; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL;

BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY DISEASE; CORONARY VESSELS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0029958038     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050581     Document Type: Article

References (48)

1. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
2. Reaven GM (1988) Banting Lecture. Role of insulin resistance in human disease. Diabetes 37: 1595-1607
3. Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422
4. Ferrannini E, Buzzigoli G, Bonadonna R (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
5. Reaven GM (1991) Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: parallels between human disease and rodent models. Diabetes Care 14: 195-202
6. Stern MP, Haffner SM (1986) Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 6: 123-130
7. DeFronzo RA (1988) Lilly Lecture. The triumvirate: beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687
8. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368
9. Reaven GM, Hollenbeck CB, Chen Y-Di (1989) Relationship between glucose tolerance, insulin secretion and insulin action in nonobese individuals with varying degrees of glucose tolerance. Diabetologia 32: 52-55
10. Bonora E, Del Prato S, Bonadonna RC (1992) Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41: 1151-1159
11. Cruz AB, Amatuzio DS, Grande F, Hay LJ (1961) Effect of intraarterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res 9: 39-43
12. Duff GL, McMillan GC (1949) The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. I. The inhibition of experimental cholesterol atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis. J Exp Med 89: 611-629
13. Stamler J, Pick R, Katz LN (1960) Effect of insulin in the induction and regression of atherosclerosis in the chick. Circ Res 8: 572-576
14. Welborn JA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154-160
15. Fonthonne A, Charles MA, Thibult N (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study. 15-year follow-up. Diabetologia 34: 356-361
16. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J (1985) Plasma insulin and coronary heart disease risk factor relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 701 [Suppl]: 38-52
17. Yarnell JWG, Sweetnam PM, Marks V, Teale JD, Bolton CH (1994) Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations. The Caerphilly prospective study. Br Heart J 171: 293-296
18. Despres JP, Lamarche B, Mauriege Pet al. (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. NEJM 334: 952-957
19. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG (1993) Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 87: 152-161
20. Turner RC (1985) United Kingdom prospective diabetes study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 7 [Suppl II]: 8-13
21. Pyörälä K, Uusitupa M, Laakso M, Siitonen O, Niskanen L, Ronnemaa T (1987) Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabetes Metab 13: 345-349 Rev
22. Hillson RM, Hockaday TD, Mann JI, Newton DJ (1984) Hyperinsulinaemia is associated with development of electrocardiographic abnormalities in diabetics. Diabetes Res 1: 143-149
23. Standl E, Janka HU (1985) High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. Horm Metab Res 15 [Suppl]: 46-51
24. Ronnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P (1991) High fasting plasma insulin as an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Throm 11: 80-90
25. Laakso M, Sarlund H, Salonen R et al. (1991) Asymptomatic atherosclerosis and insulin resistance. Arterioscler Throm 11: 1068-1076
26. Coleman TG, Manning RD Jr, Norman RA Jr, Guyton AC (1972) Dynamics of water-isotope distribution. Am J Physiol 223: 1371-1375
27. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 232: E214-E223
28. Simonson DC, DeFronzo RA (1990) Indirect calorimetry: methodological and interpretative problems. Am J Physiol 258: E399-E412
29. Miles JR, Glassock J, Aikens J, Gerich J, Haymond M (1983) A microfluorimetric method of free fatty acid in plasma. J Lipid Res 24: 96-99
30. Somogyi M (1930) A method for the preparation of blood filtrates for the determination of sugar. J Biol Chem 86: 655-663
31. Steele R, Wall JS, DeBodo RC, Altszuler N (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-25
32. 13C nuclear magnetic resonance spectroscopy. NEJM 322: 223-228
33. Sheu WH-H, Jeng C-Y, Shich S-M et al. (1992) Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 5: 444-448
34. Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165-171
35. Paolisso G, Gambardella A, Galzerano D et al. (1993) Metabolic features of patients with and without coronary heart disease but with a superimposable cluster of cardiovascular risk factors. Cor Art Dis 4: 1085-1091
36. Reaven GM, Chen Y-DI, Jeppesen J, Maheaux P, Krauss RM (1993) Insulin resistance and hyperinsulinemia in individuals with small. dense low density lipoprotein particles. J Clin Invest 92: 141-146
37. Aherg H, Lithell H, Selinius I, Hedstrand H (1985) Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris: results from a 10-year follow-up of Uppsala primary prevention study. Atherosclerosis 54: 89-97
38. Castelli WP (1986) The triglyceride issue: A view from Framingham. Am Heart J 112: 432-437
39. Falholt K, Cutfield R, Alejandro R, Heding L, Mintz D (1985) The effects of hyperinsulinemia on arterial wall and peripheral muscle metabolism in dogs. Metabolism 34: 1146-1149
40. Sato Y, Shiraishi S, Oshida Y, Ishiguro T, Sakamoto N (1989) Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes 38: 91-96
41. Stout RW (1991) Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 90: 62S-65S
42. Kannel WB, Neaton JD, Wentworth D et al. (1986) Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J 112: 825-836
43. Warram JH, Latfel LMB, Valsania P, Christlieb AR, Krowlewski AS (1991) Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Int Med 151: 1350-1356
44. Klein R, Moss SE, Klein BE, De Mets DL (1989) Relation of ocular and systemic factors to survival in diabetes. Areh Int Med 149: 266-272
45. Kuller LH, Hulley SB, Cohen JD, Neaton J (1986) Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis. Circulation 73: 114-123
46. Bressler P, DeFronzo RA (1994) Drugs and diabetes. Diabetes Reviews 2: 53-84
47. Lithell HO (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14: 203-209
48. Collins R, Peto R, MacMahon S et al. (1990) Blood pressure, stroke and coronary heart disease. Part II: Effects of short-term reductions in blood pressure - an overview of the unconfounded randomized drug trials in an epidemiological context. Lancet 335: 827-838